Novartis's new marker-gene system targets genetically modified crops

Article Abstract:

Novartis introduces a new marker-gene system that it hopes will quell farmers' fears of transgenic plants. The company intends to distribute the product among farmers in developing countries for free.

Biochemistry, Research and Development in the Physical, Engineering, and Life Sciences, Product introduction, Statistical Data Included, Biotechnology industry, Biotechnology industries, Brief Article, Genetically modified plants

---

Novartis unveils restructuring of its main drug division

Article Abstract:

Novartis AG has revealed the restructuring plan of its flagship drug division. The restructuring is intended to increase the company's marketing power before the launch of several new drugs.

Organizational history, Management

---

Novartis 11% profit increase, full-year results beat expectations

Article Abstract:

Novartis AG posted an improvement of 11% in its profits for the 1999 year. The company posted 3.68 billion Swiss francs (2.29 billion euros) in pretax profits for the year.

Sales, profits & dividends, Finance

Similar abstracts:

• Abstracts: World Online 's founder admits link to five failed companies. World Online plans give-back offer for worker shares
• Abstracts: Caterpillar's net in fourth quarter beats Wall Street estimates. Caterpillar net jumps 26%, tops analyst forecasts
• Abstracts: Spain's Santander, Abbey National of U.K. poised for $15 billion deal . Standard Chartered bids to buy Grindlays for $1.6 billion
• Abstracts: The top air cargo carriers: new services make the difference. Luxury consumers like it different
• Abstracts: Fenosa is given the green light to take over rival Cantabrico. Shareholders reject Fenosa's offer to buy Cantabrico

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.